Hemoglobinopathy: Difference between revisions
No edit summary |
|||
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
'''Hemoglobinopathy''' is a kind of [[gene]]tic defect that results in [[abnormal]] structure of one of the [[globin]] [[chain]]<nowiki/>s of the [[hemoglobin]] [[molecule]]. Most common hemoglobinopathies include [[sickle-cell disease]]. | '''Hemoglobinopathy''' is a kind of [[gene]]tic defect that results in [[abnormal]] structure of one of the [[globin]] [[chain]]<nowiki/>s of the [[hemoglobin]] [[molecule]]. Most common hemoglobinopathies include [[sickle-cell disease]].The renge of clinical manifestations of the hemoglobinopathies are from mild hypochromic anemia to moderate hematological disease to severe. | ||
==Classification== | ==Classification== | ||
Line 23: | Line 24: | ||
The renge of clinical manifestations of the hemoglobinopathies are from mild hypochromic anemia to moderate hematological disease to severe | |||
== Migration patterns == | == Migration patterns == | ||
Line 33: | Line 35: | ||
===Prevalence=== | ===Prevalence=== | ||
*In 2008, the prevalence of hemoglobinopathy was estimated to be 7% of the worldwide population being carrier.<ref name="pmid21886666">{{cite journal |vauthors=Kohne E |title=Hemoglobinopathies: clinical manifestations, diagnosis, and treatment |journal=Dtsch Arztebl Int |volume=108 |issue=31-32 |pages=532–40 |date=August 2011 |pmid=21886666 |pmc=3163784 |doi=10.3238/arztebl.2011.0532 |url=}}</ref> | *In 2008, the prevalence of hemoglobinopathy was estimated to be 7% of the worldwide population being carrier.<ref name="pmid21886666">{{cite journal |vauthors=Kohne E |title=Hemoglobinopathies: clinical manifestations, diagnosis, and treatment |journal=Dtsch Arztebl Int |volume=108 |issue=31-32 |pages=532–40 |date=August 2011 |pmid=21886666 |pmc=3163784 |doi=10.3238/arztebl.2011.0532 |url=}}</ref> | ||
*The most prevalance of hemoglobinopathy gene carriers in the world's are in South-East Asia(up to 70%) and Arab nations(up to 60).<ref name="pmid21886666" /> | |||
*In Russia is seen rare<ref name="pmid21886666" /> | |||
*Recent years is increased in Germany.<ref name="pmid10663615">{{cite journal |vauthors=Cario H, Stahnke K, Sander S, Kohne E |title=Epidemiological situation and treatment of patients with thalassemia major in Germany: results of the German multicenter beta-thalassemia study |journal=Ann. Hematol. |volume=79 |issue=1 |pages=7–12 |date=January 2000 |pmid=10663615 |doi= |url=}}</ref> | |||
===Race=== | ===Race=== | ||
Line 42: | Line 47: | ||
It occure cur mainly in Mediterranean countries, South-East Europe, Arab nations and Asia. | It occure cur mainly in Mediterranean countries, South-East Europe, Arab nations and Asia. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 15:08, 4 September 2018
Template:Search infobox Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]
Overview
Hemoglobinopathy is a kind of genetic defect that results in abnormal structure of one of the globin chains of the hemoglobin molecule. Most common hemoglobinopathies include sickle-cell disease.The renge of clinical manifestations of the hemoglobinopathies are from mild hypochromic anemia to moderate hematological disease to severe.
Classification
Hemoglobinopathy be classified according to genetic and structure of hemoglobin into two main groups:
- Thalassemia syndromes
- α-thalassemia
- β-thalassemia
- Structural hemoglobin variants
- HbS
- HbE
- HbC
- Hb Bart’s
- Hb J(Johnstown)
- HbM
- HbX
- Hb D
The renge of clinical manifestations of the hemoglobinopathies are from mild hypochromic anemia to moderate hematological disease to severe
Migration patterns
Epidemiology and Demographics
Incidence
- The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.[1]
Prevalence
- In 2008, the prevalence of hemoglobinopathy was estimated to be 7% of the worldwide population being carrier.[1]
- The most prevalance of hemoglobinopathy gene carriers in the world's are in South-East Asia(up to 70%) and Arab nations(up to 60).[1]
- In Russia is seen rare[1]
- Recent years is increased in Germany.[2]
Race
α-thalassemias
It occure cur mainly in Africa, Arab nations, and, more frequently and South-East Asia.
β-thalassemias
It occure cur mainly in Mediterranean countries, South-East Europe, Arab nations and Asia.
References
- ↑ 1.0 1.1 1.2 1.3 Kohne E (August 2011). "Hemoglobinopathies: clinical manifestations, diagnosis, and treatment". Dtsch Arztebl Int. 108 (31–32): 532–40. doi:10.3238/arztebl.2011.0532. PMC 3163784. PMID 21886666.
- ↑ Cario H, Stahnke K, Sander S, Kohne E (January 2000). "Epidemiological situation and treatment of patients with thalassemia major in Germany: results of the German multicenter beta-thalassemia study". Ann. Hematol. 79 (1): 7–12. PMID 10663615.